AzTrials
AzTrials

Health BehaviorNCT06296355

Impacts of Warning Labels on Ultra-Processed Foods

A study testing Health Warning Label, Identity Warning Label and Barcode Label in people with Health Behavior and Diet, Healthy, run by University of North Carolina, Chapel Hill at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode). Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Health Behavior, Diet, Healthy
What is being tested?
Health Warning Label, Identity Warning Label and Barcode Label
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4,000 participants
Where
1 siteUnited States
Study dates
9 Aug 2024to 11 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Identifying as Latino or Hispanic
  • Ages 18-55 years old
  • Currently resides in the United States

Who cannot join

  • Not identifying as Latino or Hispanic
  • Less than 18 or greater than 55 years old
  • Not residing in the United States

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UNC Carolina Population Center

    Chapel Hill, North Carolina, 27516

Other trials in United States

About this study

Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode).

Participants: ~4,000 US Latino adults of parental age (18-55 years), approximately 50% of whom will have limited English proficiency, recruited from a Latino-focused panel company.

Procedures: Participants will be randomly assigned to view food products with one of three label types: health warning labels, identity labels, or barcode control labels. Participants will be asked a series of questions about the products and the label they were assigned.

Read the detailed description

On the study platform (Qualtrics), participants will be randomly assigned to 1 of 3 arms with equal probability: a UPF health warning label, a UPF identity label, or a barcode control label. Participants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) displayed in random order, each with a label displayed on the front of package according to the participants' study arm. Participants will complete a 13-item online survey to assess each product as to a) whether the product is ultra-processed; b) perceptions of healthfulness; c) intentions to purchase the product.

Being tested
Health Warning Label, Identity Warning Label, Barcode Label
Keywords
front-of-package labels, ultra-processed food, food and beverage purchases
Medical subject headings
Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health Warning LabelBehavioural

    Message displayed on warning label is: "WARNING: Consuming ultra-processed food and drinks can cause weight gain, which increases the risk of obesity and type 2 diabetes."

  • Identity Warning LabelBehavioural

    Message displayed on warning label is: "WARNING: Ultra-processed food".

  • Barcode LabelOther

    Barcode is displayed.

Study groups in NCT06296355
Study groupRoleWhat they receive
Health Warning LabelExperimentalParticipants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with a health warning label displayed on the front of package.
Receives: Behavioral: Health Warning Label
Identity Warning LabelExperimentalParticipants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with an identity warning label displayed on the front of package.
Receives: Behavioral: Identity Warning Label
Barcode LabelOtherParticipants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with a barcode control label displayed on the front of package.
Receives: Other: Barcode Label

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identification of a product as ultra-processed

    Correct identification of a product as ultra-processed. Measured with the question, "Do you think this product is ultra-processed?" Response options are Yes, No, and I'm not sure.

    Measured: Immediately after exposure to intervention, assessed during 1-time online study visit.

Secondary outcomes (3)
  1. Perceived product healthfulness of ultra-processed products

    Measured with the question, "How good or bad for your health would it be to consume this product every day?" Likert responses are on a 1 to 5 scale, from "Very bad" (coded as 1) to "Very good" (coded as 5), with higher scores representing a higher perceived healthfulness.

    Measured: Immediately after exposure to intervention, assessed during 1-time online study visit.

  2. Intentions to purchase ultra-processed products

    Measured with the question, "How likely would you be to purchase this product in the next week, if it were available?" Likert responses are on a 1 to 5 scale, from "Not at all likely" (coded as 1) to "Extremely likely" (coded as 5), with higher scores representing a higher intention to purchase ultra-processed products.

    Measured: Immediately after exposure to intervention, assessed during 1-time online study visit.

  3. Perceived message effectiveness

    Measured with the question, "How much does this message discourage you from wanting to consume an ultra-processed food or drink?" Likert responses are on a 1 to 5 scale, from "Not at all" (coded as 1) to "Very much" (coded as 5), with higher scores representing a higher perceived message effectiveness.

    Measured: Immediately after exposure to intervention, assessed during 1-time online study visit.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2024
  2. Study start9 Aug 2024
  3. Primary completion11 Sep 2024
  4. Study completion11 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
4,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06296355
Sponsor's protocol ID
24-0300d
Status last verified
Oct 2024
First submitted
28 Feb 2024
Last updated
15 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: A deidentified dataset and the corresponding survey codebook will be shared beginning 9 months and continuing for 36 months after publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC. The study protocol, statistical analysis plan, and informed consent form will be published alongside as supplementary material.

Questions about this trial

What is this clinical trial studying?

A study testing Health Warning Label, Identity Warning Label and Barcode Label in people with Health Behavior and Diet, Healthy, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identification of a product as ultra-processed (time frame: Immediately after exposure to intervention, assessed during 1-time online study visit.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in